Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple shot of gentamicin during C-Sections stop infections?

NCT ID NCT07311395

Prevention Sponsor: Western Galilee Hospital-Nahariya Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study is testing whether giving a single injection of the antibiotic gentamicin into the surgical wound during a planned C-section can reduce the risk of infection afterward. Researchers will compare 100 women who receive this extra local antibiotic plus standard IV antibiotics to those who get standard care alone. Participants are followed for 30 days to check for wound infections and other complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
gentamicin
What this could lead to
If it works, this could offer a simple, low-cost way to prevent wound infections after planned C-sections.
What could go wrong
This is a small pilot study, so results may not be conclusive. The added benefit over standard antibiotics alone is uncertain, and there is a risk of allergic reactions or side effects from gentamicin.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 years and older. * Undergoing elective cesarean section. * Gestational age \>= 24 weeks. * Planned postoperative follow-up of 30 days. * Eligible for standard antibiotic prophylaxis according to institutional protocol. * Able to provide informed consent. Exclusion Criteria: * Known allergy of hypersensitivity to aminoglycosides. * Known allergy of hypersensitivity to systemic antibiotic prophylaxis agents. * Current or planned use of immunomodulatory or immunosuppressive therapy. * Requirement for therapeutic ( non- prophylactic) antibiotic treatment at the time of surgery. * Active infection or clinical condition requiring antibiotic treatment. * Inability or unwillingness to comply with study procedures or follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Surgical site infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Surgical site infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Western Galilee Hospital-Nahariya

    RECRUITING

    Nahariya, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.